These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 7682909)
1. Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Brogden RN; Goa KL; Faulds D Drugs; 1993 Mar; 45(3):384-409. PubMed ID: 7682909 [TBL] [Abstract][Full Text] [Related]
2. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Ashok PW; Flett GM; Templeton A Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353 [TBL] [Abstract][Full Text] [Related]
3. Mifepristone: contraceptive and non-contraceptive uses. Ho PC; Yu Ng EH; Tang OS Curr Opin Obstet Gynecol; 2002 Jun; 14(3):325-30. PubMed ID: 12032390 [TBL] [Abstract][Full Text] [Related]
8. Mifepristone. DeHart RM; Morehead MS Ann Pharmacother; 2001 Jun; 35(6):707-19. PubMed ID: 11408990 [TBL] [Abstract][Full Text] [Related]
9. Mifepristone: current knowledge and emerging prospects. Kakade AS; Kulkarni YS J Indian Med Assoc; 2014 Jan; 112(1):36-40. PubMed ID: 25935948 [TBL] [Abstract][Full Text] [Related]
10. Clinical uses of antiprogestogens. Van Look PF; von Hertzen H Hum Reprod Update; 1995 Jan; 1(1):19-34. PubMed ID: 9080204 [TBL] [Abstract][Full Text] [Related]
11. [Methods of second trimester pregnancy termination and evacuation of in utero dead fetuses. Value of mifepristone]. Maria B; Matheron I J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):642-50. PubMed ID: 7995906 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of mifepristone: toxicology and safety in animal and human studies. Sitruk-Ware R; Spitz IM Contraception; 2003 Dec; 68(6):409-20. PubMed ID: 14698070 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of mifepristone. Heikinheimo O Clin Pharmacokinet; 1997 Jul; 33(1):7-17. PubMed ID: 9250420 [TBL] [Abstract][Full Text] [Related]
15. Approval of mifepristone (RU 486) in Europe. Sitruk-Ware R Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210 [TBL] [Abstract][Full Text] [Related]
16. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial. Ho PC; Chan YF; Lau W Contraception; 1996 May; 53(5):281-3. PubMed ID: 8724617 [TBL] [Abstract][Full Text] [Related]
17. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426 [TBL] [Abstract][Full Text] [Related]
18. Clinical applications of mifepristone. Tang OS; Ho PC Gynecol Endocrinol; 2006 Dec; 22(12):655-9. PubMed ID: 17162706 [TBL] [Abstract][Full Text] [Related]
19. [Use of mifepristone in the termination of early pregnancy. The experience in France]. Dubois C; Silvestre L; Ulmann A Presse Med; 1989 Apr; 18(15):757-60. PubMed ID: 2524050 [TBL] [Abstract][Full Text] [Related]
20. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation. Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]